CD163 and neoplasm: The aim of study was to identify the potential association between TYMP and CD163 gene expression and relapse-free survival (RFS), along with the clinicopathological factors of patients with stage II CRC, as well as the variation in expression in macro- and microdissected tumor tissues, the latter being divided into tumor epithelial cells and stroma cells.